Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of GB SCIENCES INC from Q1 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
GB SCIENCES INC quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q1 2013 to Q4 2024.
  • GB SCIENCES INC Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Dec 2024 was $-5,880,014, a 21.3% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

GB SCIENCES INC Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $-5,880,014 -$1,032,946 -21% 31 Dec 2024 10-Q 12 Aug 2025 2025 Q3
Q3 2024 $-5,779,659 -$1,086,533 -23% 30 Sep 2024 10-Q 12 Aug 2025 2025 Q3
Q2 2024 $-5,589,133 -$908,629 -19% 30 Jun 2024 10-Q 27 Nov 2024 2025 Q2
Q1 2024 $-5,314,115 -$906,732 -21% 31 Mar 2024 10-Q 12 Aug 2025 2025 Q3
Q4 2023 $-4,847,068 -$3,235,361 -201% 31 Dec 2023 10-Q 12 Aug 2025 2025 Q3
Q3 2023 $-4,693,126 -$3,499,758 -293% 30 Sep 2023 10-Q 12 Aug 2025 2025 Q3
Q2 2023 $-4,680,504 -$2,514,793 -116% 30 Jun 2023 10-Q 27 Nov 2024 2025 Q2
Q1 2023 $-4,407,383 -$2,624,511 -147% 31 Mar 2023 10-Q 12 Aug 2025 2025 Q3
Q4 2022 $-1,611,707 -$3,414,405 -189% 31 Dec 2022 10-Q 12 Feb 2024 2024 Q3
Q3 2022 $-1,193,368 +$1,344,638 +53% 30 Sep 2022 10-Q 12 Feb 2024 2024 Q3
Q2 2022 $-2,165,711 -$135,260 -6.7% 30 Jun 2022 10-Q 20 Nov 2023 2024 Q2
Q1 2022 $-1,782,872 -$308,944 -21% 31 Mar 2022 10-K 30 Aug 2024 2024 FY
Q4 2021 $1,802,698 +$4,298,774 31 Dec 2021 10-Q 03 Feb 2023 2022 Q3
Q3 2021 $-2,538,006 -$188,435 -8% 30 Sep 2021 10-Q 03 Feb 2023 2022 Q3
Q2 2021 $-2,030,451 -$381,338 -23% 30 Jun 2021 10-Q 09 Nov 2022 2022 Q2
Q1 2021 $-1,473,928 -$1,385,434 -1,566% 31 Mar 2021 10-K 14 Jul 2023 2023 FY
Q4 2020 $-2,496,076 -$10,798,059 -130% 31 Dec 2020 10-Q 11 Feb 2022 2022 Q3
Q3 2020 $-2,349,571 -$16,665,234 -116% 30 Sep 2020 10-Q 11 Feb 2022 2022 Q3
Q2 2020 $-1,649,113 -$17,259,951 -111% 30 Jun 2020 10-Q 15 Nov 2021 2022 Q2
Q1 2020 $-88,494 -$17,244,493 -101% 31 Mar 2020 10-K 30 Jun 2022 2022 FY
Q4 2019 $8,301,983 -$11,068,887 -57% 31 Dec 2019 10-Q 18 Feb 2020 2020 Q3
Q3 2019 $14,315,663 -$7,691,389 -35% 30 Sep 2019 10-Q 18 Feb 2020 2020 Q3
Q2 2019 $15,610,838 -$4,277,334 -22% 30 Jun 2019 10-Q 15 Nov 2019 2020 Q2
Q1 2019 $17,155,999 +$1,524,278 +9.8% 31 Mar 2019 10-K 06 Jul 2021 2021 FY
Q4 2018 $19,370,870 +$10,894,878 +129% 31 Dec 2018 10-Q 18 Feb 2020 2020 Q3
Q3 2018 $22,007,052 +$14,342,818 +187% 30 Sep 2018 10-Q 18 Feb 2020 2020 Q3
Q2 2018 $19,888,172 +$12,464,050 +168% 30 Jun 2018 10-Q 15 Nov 2019 2020 Q2
Q1 2018 $15,631,721 +$7,227,040 +86% 31 Mar 2018 10-K 28 Aug 2020 2020 FY
Q4 2017 $8,475,992 +$4,834,320 +133% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q3
Q3 2017 $7,664,234 +$5,581,724 +268% 30 Sep 2017 10-Q 20 Nov 2017 2018 Q2
Q2 2017 $7,424,122 +$8,086,799 30 Jun 2017 10-Q 14 Aug 2017 2018 Q1
Q1 2017 $8,404,681 +$10,379,595 31 Mar 2017 10-K 15 Jul 2019 2019 FY
Q4 2016 $3,641,672 +$4,722,403 31 Dec 2016 10-Q 14 Feb 2017 2017 Q3
Q3 2016 $2,082,510 +$2,484,023 30 Sep 2016 10-Q 14 Nov 2016 2017 Q2
Q2 2016 $-662,677 +$673,634 +50% 30 Jun 2016 10-Q 15 Aug 2016 2017 Q1
Q1 2016 $-1,974,914 -$43,749 -2.3% 31 Mar 2016 10-K 29 Jun 2018 2018 FY
Q4 2015 $-1,080,731 -$2,125,442 -203% 31 Dec 2015 10-Q 16 Feb 2016 2016 Q3
Q3 2015 $-401,513 -$2,372,484 -120% 30 Sep 2015 10-Q 18 Nov 2015 2016 Q2
Q2 2015 $-1,336,311 -$4,094,711 -148% 30 Jun 2015 10-Q 20 Aug 2015 2016 Q1
Q1 2015 $-1,931,165 -$917,796 -91% 31 Mar 2015 10-K 14 Jul 2017 2017 FY
Q4 2014 $1,044,711 31 Dec 2014 10-Q 17 Feb 2015 2015 Q3
Q3 2014 $1,970,971 30 Sep 2014 10-Q 14 Nov 2014 2015 Q2
Q2 2014 $2,758,400 30 Jun 2014 10-Q 14 Aug 2014 2015 Q1
Q1 2014 $-1,013,369 +$176,318 +15% 31 Mar 2014 10-K 15 Jul 2016 2016 FY
Q1 2013 $-1,189,687 31 Mar 2013 10-K 15 Jul 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.